674 related articles for article (PubMed ID: 19738171)
1. Systemic inflammation and disease progression in Alzheimer disease.
Holmes C; Cunningham C; Zotova E; Woolford J; Dean C; Kerr S; Culliford D; Perry VH
Neurology; 2009 Sep; 73(10):768-74. PubMed ID: 19738171
[TBL] [Abstract][Full Text] [Related]
2. Longitudinal study of inflammatory factors in serum, cerebrospinal fluid, and brain tissue in Alzheimer disease: interleukin-1beta, interleukin-6, interleukin-1 receptor antagonist, tumor necrosis factor-alpha, the soluble tumor necrosis factor receptors I and II, and alpha1-antichymotrypsin.
Lanzrein AS; Johnston CM; Perry VH; Jobst KA; King EM; Smith AD
Alzheimer Dis Assoc Disord; 1998 Sep; 12(3):215-27. PubMed ID: 9772027
[TBL] [Abstract][Full Text] [Related]
3. IFN-γ and TNF-α are involved during Alzheimer disease progression and correlate with nitric oxide production: a study in Algerian patients.
Belkhelfa M; Rafa H; Medjeber O; Arroul-Lammali A; Behairi N; Abada-Bendib M; Makrelouf M; Belarbi S; Masmoudi AN; Tazir M; Touil-Boukoffa C
J Interferon Cytokine Res; 2014 Nov; 34(11):839-47. PubMed ID: 24831467
[TBL] [Abstract][Full Text] [Related]
4. The Independent Role of Inflammation in Physical Frailty among Older Adults with Mild Cognitive Impairment and Mild-to-Moderate Alzheimer's Disease.
Tay L; Lim WS; Chan M; Ye RJ; Chong MS
J Nutr Health Aging; 2016 Mar; 20(3):288-99. PubMed ID: 26892578
[TBL] [Abstract][Full Text] [Related]
5. Tumor necrosis factor-α synthesis inhibitor 3,6'-dithiothalidomide attenuates markers of inflammation, Alzheimer pathology and behavioral deficits in animal models of neuroinflammation and Alzheimer's disease.
Tweedie D; Ferguson RA; Fishman K; Frankola KA; Van Praag H; Holloway HW; Luo W; Li Y; Caracciolo L; Russo I; Barlati S; Ray B; Lahiri DK; Bosetti F; Greig NH; Rosi S
J Neuroinflammation; 2012 May; 9():106. PubMed ID: 22642825
[TBL] [Abstract][Full Text] [Related]
6. Systemic inflammation and disease progression in Alzheimer disease.
Kamer AR
Neurology; 2010 Apr; 74(14):1157; author reply 1157-8. PubMed ID: 20368640
[No Abstract] [Full Text] [Related]
7. Proinflammatory cytokines, sickness behavior, and Alzheimer disease.
Holmes C; Cunningham C; Zotova E; Culliford D; Perry VH
Neurology; 2011 Jul; 77(3):212-8. PubMed ID: 21753171
[TBL] [Abstract][Full Text] [Related]
8. Serum inflammatory proteins and cognitive decline in older persons.
Dik MG; Jonker C; Hack CE; Smit JH; Comijs HC; Eikelenboom P
Neurology; 2005 Apr; 64(8):1371-7. PubMed ID: 15851726
[TBL] [Abstract][Full Text] [Related]
9. Food anthocyanins decrease concentrations of TNF-α in older adults with mild cognitive impairment: A randomized, controlled, double blind clinical trial.
do Rosario VA; Fitzgerald Z; Broyd S; Paterson A; Roodenrys S; Thomas S; Bliokas V; Potter J; Walton K; Weston-Green K; Yousefi M; Williams D; Wright IMR; Charlton K
Nutr Metab Cardiovasc Dis; 2021 Mar; 31(3):950-960. PubMed ID: 33546942
[TBL] [Abstract][Full Text] [Related]
10. Periodontitis and Cognitive Decline in Alzheimer's Disease.
Ide M; Harris M; Stevens A; Sussams R; Hopkins V; Culliford D; Fuller J; Ibbett P; Raybould R; Thomas R; Puenter U; Teeling J; Perry VH; Holmes C
PLoS One; 2016; 11(3):e0151081. PubMed ID: 26963387
[TBL] [Abstract][Full Text] [Related]
11. Serum pentraxin-3 and tumor necrosis factor-like weak inducer of apoptosis (TWEAK) predict severity of infections in acute decompensated cirrhotic patients.
Fan WC; Huang CC; Yang YY; Lin A; Lee KC; Hsieh YC; Fung CP; Hsu HC; Hou MC; Lin HC
J Microbiol Immunol Infect; 2017 Dec; 50(6):905-914. PubMed ID: 26872435
[TBL] [Abstract][Full Text] [Related]
12. Blood Inflammatory Mediators and Cognitive Decline in Alzheimer's Disease: A Two Years Longitudinal Study.
Julian A; Rioux-Bilan A; Ragot S; Krolak-Salmon P; Berrut G; Dantoine T; Hommet C; Hanon O; Page G; Paccalin M
J Alzheimers Dis; 2018; 63(1):87-92. PubMed ID: 29614665
[TBL] [Abstract][Full Text] [Related]
13. Association of inflammatory biomarkers with depressive symptoms and cognitive decline in a community-dwelling healthy older sample: a 3-year follow-up study.
Matsushima J; Kawashima T; Nabeta H; Imamura Y; Watanabe I; Mizoguchi Y; Kojima N; Yamada S; Monji A
J Affect Disord; 2015 Mar; 173():9-14. PubMed ID: 25462389
[TBL] [Abstract][Full Text] [Related]
14. Inflammatory markers and the risk of Alzheimer disease: the Framingham Study.
Tan ZS; Beiser AS; Vasan RS; Roubenoff R; Dinarello CA; Harris TB; Benjamin EJ; Au R; Kiel DP; Wolf PA; Seshadri S
Neurology; 2007 May; 68(22):1902-8. PubMed ID: 17536046
[TBL] [Abstract][Full Text] [Related]
15. Inflammatory proteins in plasma are associated with severity of Alzheimer's disease.
Leung R; Proitsi P; Simmons A; Lunnon K; Güntert A; Kronenberg D; Pritchard M; Tsolaki M; Mecocci P; Kloszewska I; Vellas B; Soininen H; Wahlund LO; Lovestone S
PLoS One; 2013; 8(6):e64971. PubMed ID: 23762274
[TBL] [Abstract][Full Text] [Related]
16. Higher serum sTNFR1 level predicts conversion from mild cognitive impairment to Alzheimer's disease.
Diniz BS; Teixeira AL; Ojopi EB; Talib LL; Mendonça VA; Gattaz WF; Forlenza OV
J Alzheimers Dis; 2010; 22(4):1305-11. PubMed ID: 20930310
[TBL] [Abstract][Full Text] [Related]
17. Correlation of severity of chronic obstructive pulmonary disease with potential biomarkers.
Singh S; Verma SK; Kumar S; Ahmad MK; Nischal A; Singh SK; Dixit RK
Immunol Lett; 2018 Apr; 196():1-10. PubMed ID: 29329680
[TBL] [Abstract][Full Text] [Related]
18. Association of monocyte tumor necrosis factor α expression and serum inflammatory biomarkers with walking impairment in peripheral artery disease.
Pande RL; Brown J; Buck S; Redline W; Doyle J; Plutzky J; Creager MA
J Vasc Surg; 2015 Jan; 61(1):155-61. PubMed ID: 25095746
[TBL] [Abstract][Full Text] [Related]
19. Proinflammatory and anti-inflammatory cytokines in the CSF of patients with Alzheimer's disease and their correlation with cognitive decline.
Taipa R; das Neves SP; Sousa AL; Fernandes J; Pinto C; Correia AP; Santos E; Pinto PS; Carneiro P; Costa P; Santos D; Alonso I; Palha J; Marques F; Cavaco S; Sousa N
Neurobiol Aging; 2019 Apr; 76():125-132. PubMed ID: 30711675
[TBL] [Abstract][Full Text] [Related]
20. Macrophage migration inhibitory factor in mild cognitive impairment and Alzheimer's disease.
Popp J; Bacher M; Kölsch H; Noelker C; Deuster O; Dodel R; Jessen F
J Psychiatr Res; 2009 May; 43(8):749-53. PubMed ID: 19038405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
